The Substance Abuse and Mental Health Services Administration (SAMHSA) announced the upcoming launch of MATx, a free mobile app that will provide health care practitioners with immediate access to vital information about medication-assisted treatment (MAT) for opioid use disorder.
“There’s nothing like MATx in the field today,” said SAMHSA Principal Deputy Administrator, Kana Enomoto. “It will be a significant step forward in improving timely access to medication–assisted treatment by enabling physicians and other health care practitioners to better provide effective, evidence-based, and in some cases, life-saving treatment to people with opioid use disorders.”
Key features of the MATx app include:
- Information on medications approved by the U.S. Food and Drug Administration for use in the treatment of opioid use disorders and treatment approaches for practitioners.
- A buprenorphine prescribing guide, which includes information on the Drug Addiction Treatment Act of 2000 (DATA 2000) waiver process and patient limits
- Clinical support tools such as treatment guidelines, ICD-10 coding, continuing education opportunities, and recommendations for working with special populations
- Access to critical helplines and SAMHSA’s treatment locators.
SAMHSA will officially launch its MATx app on October 21, 2016.
More information about the free app and how to download it to a mobile device is available at http://store.samhsa.gov/apps/MAT.